A 10-Week Randomized, Multicenter, Double-Blind, Parallel, Fixed-Dose Study of MDX (Methadoxine Immediate-Release/Slow-Release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)

Dr. Keith McBurnett is recruiting adults with ADHD for a 10-week study evaluating an investigational medication. Interested subjects can call or email the center for a confidential phone interview screening.

Study design

Participants may receive psychiatric evaluation, medical exam, blood draws, and electrocardiogram (ECG) to determine eligibility. Eligible participants will receive the study drug or a placebo and return to the clinic for evaluations over a 10-week period. A placebo resembles the study drug, but has no active ingredients.

Participant requirements

Participants must be a male or a non-pregnant, non-lactating female 18 to 55 years of age.

Principal investigator

Contact information

You may contact the study coordinator and other study research assistants by sending an email to melissa.plageman@ucsf.edu or by calling (415) 476-7123.